|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases |
|
|
P/S
|
Printed publications for investors and customers, namely, financial reports, corporate literature... |
|
|
P/S
|
Printed publications for investors and customers, namely,
financial reports, corporate literatur... |
|
|
P/S
|
printed publications for investors and customers, namely, financial reports, corporate literature... |
|
|
P/S
|
Provision of information and materials on pharmaceutical treatments, disease awareness, treatment... |
|
2024
|
P/S
|
Providing medical and scientific research information in the field of pharmaceuticals and clinica... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations... |
|
|
Invention
|
Pharmaceutical compositions comprising 2,3,4,5-tetrahydro-benzothiepin-1,1-dioxide derivatives an... |
|
|
Invention
|
Pharmaceutical compositions comprising 2,3,4,5- tetrahydrobenzothiepin- 1,1-dioxide derivatives a... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of bile acid metabolic disorders; pharmaceutical pr... |
|
|
P/S
|
Genetic testing kits, namely, genetic identity tests comprised of reagents for medical purposes.
... |
|
|
P/S
|
Genetic testing kits comprised of medical specimen collection devices in the nature of glass tube... |
|
|
P/S
|
Genetic testing kits.
Printed publications featuring information relating to genetic testing kits... |
|
|
Invention
|
Methods for treating cholestasis.
Provided herein are methods for treating cholestasis in a subj... |
|
2023
|
Invention
|
Methods for treating progressive familial intrahepatic cholestasis.
Provided herein are methods ... |
|
|
Invention
|
Methods for treating progressive familial intrahepatic cholestasis. Provided herein are methods f... |
|
|
Invention
|
Pharmaceutical compositions comprising maralixibat and uses thereof. The invention relates to a p... |
|
|
Invention
|
Maralixibat solid forms, intermediates and processes of making same.
The present invention relat... |
|
|
Invention
|
Maralixibat solid forms, intermediates and processes of making same. The present invention relate... |
|
2022
|
Invention
|
Treatment with ileal bile acid transporter (ibat) inhibitors for increased event-free survival (e... |
|
|
Invention
|
Apical sodium-dependent transporter inhibitor compositions.
Provided herein are pharmaceutical c... |
|
|
Invention
|
Methods of dosing of apical sodium-dependent bile acid transporter inhibitors (asbtis).
The pres... |
|
|
Invention
|
Methods of dosing of apical sodium-dependent bile acid transporter inhibitors (asbtis). The prese... |
|
|
Invention
|
Apical sodium-dependent transporter inhibitor compositions. Provided herein are pharmaceutical co... |
|
|
Invention
|
Methods for treating cholestasis. Provided herein are methods for treating cholestasis in a subje... |
|
2021
|
P/S
|
Providing patient resource services, namely, information about liver diseases and disorders in th... |
|
|
P/S
|
Providing patient resource services in the form of symptom
tracking via printed materials and a ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of rare liver diseases and disorders; pharmaceutica... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver disease. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver
disease. |
|
|
P/S
|
Downloadable mobile application featuring technology that enables users to enter, access, track, ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver disease |
|
|
P/S
|
Charitable services, namely, patient assistance program to provide drugs free of charge to low-in... |
|
2020
|
P/S
|
Genetic testing for medical purposes; providing information in the field of screening, diagnosis ... |
|
|
Invention
|
Methods for increasing growth in pediatric subjects having cholestatic liver disease.
Provided h... |
|
|
Invention
|
Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficienc... |
|
|
Invention
|
Methods for increasing growth in pediatric subjects having cholestatic liver disease. Provided he... |
|
2019
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases and conditions. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases and conditions |
|
|
P/S
|
Medical health assessment instrument in the nature of a printed evaluation and diagnostic questio... |
|
2015
|
P/S
|
Pharmaceutical preparations for use in treatment of individuals with primary and secondary defect... |
|
|
P/S
|
Pharmaceutical preparations for use in treatment of
individuals with primary and secondary defec... |
|
|
P/S
|
Providing medical information, consultancy and advisory services; providing medical information r... |
|
2013
|
P/S
|
Computer application software for mobile devices, namely, software for providing printed patient-... |
|
2011
|
P/S
|
Pharmaceutical preparations containing chenodiol or derivatives thereof in oral dosage form for t... |
